Leverage reference drugs with similar pharmacology, construct PBPK model to extrapolate human PK from preclinical animal data, predict minimal effective dose and maximum tolerated dose for First-in-Human trials.
B²O Pharmaceuticals is an innovative pharmaceutical research and development company dedicated to artificial intelligence (AI)-driven clinical pharmacology and quantitative pharmacology.